In this edition of I Raise the Rates (IRtR), you will find a variety of new resources from several public health partners, educational opportunities, and a brief selection of popular media articles related to immunization.
Become an I Raise the Rates Community Champion!
Are you an immunization advocate? Apply today to become an I Raise the Rates Community Champion and take the lead in promoting adult vaccine uptake in your community.
As clinicians, you are among the most trusted messengers of health information and an important member of the community with many connections and opportunities to engage with members of the public. Click here for more information about the ACP I Raise the Rates Community Champion program.
Save The Date: The 2023 Adult Immunization Conference in Here!
The Advisory Committee on Immunization Practices (ACIP) issued its annual update on flu vaccines, including a change in recommendations regarding vaccination for people with egg allergies. Click here to read the full updates to last year's recommendations as published in the August 25th MMWR.
The RSV-NET Interactive Dashboard shows for the 2022-2023 RSV season in the U.S., the overall rate of related hospitalizations was 50.9 per 100,000 people. The U.S. Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report presented the seasonality of RSV in the U.S. from 2017–2023.
FDA Approves First Vaccine for Pregnant Individuals to prevent RSV in Infants
Today, the U.S. Food and Drug Administration approved Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age.
